Key Insights

Highlights

Treatment Research

3 treatments under study, led by Tiotropium Bromide Monohydrate

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Tiotropium Bromide Monohydrate1
  • Ttb Gel Dose 21
  • Ttb Gel Dose 11

Active Sponsors

  • Dryox Health1
  • Dryox Health S.L.1

Top Investigators

Related Conditions

  • Palmar Hyperhidrosis1

Activity Timeline